Artiva Biotherapeutics (ARTV) Selling, General & Administrative (2023 - 2026)
Artiva Biotherapeutics (ARTV) Selling, General & Administrative (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | 101.25 Mn |
| 10 | Artiva Biotherapeutics | 261.10 Mn | 261.10 Mn | - | 5.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.12 Mn |
| Dec 31, 2025 | 4.94 Mn |
| Sep 30, 2025 | 5.26 Mn |
| Jun 30, 2025 | 4.95 Mn |
| Mar 31, 2025 | 5.12 Mn |
| Dec 31, 2024 | 4.95 Mn |
| Sep 30, 2024 | 4.81 Mn |
| Jun 30, 2024 | 3.86 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 3.17 Mn |
| Sep 30, 2023 | 2.78 Mn |
| Jun 30, 2023 | 4.06 Mn |